ArticleThe Indian journal of medical research2025
Region-wise lung cancer burden, long-term trend & time-series forecasts in India: An analytical study by age, gender, & morphology.
Article in The Indian journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background & objectives Lung cancer is the most diagnosed cancer and leading cause of cancer deaths. We assessed regional patterns in incidence, mortality, morphology, and mortality-to-incidence ratio across 57 populations, along with tobacco and alcohol use in India. We also estimated time-trends (average annual percent change: AAPC) by gender and age, and forecasted to 2030. Methods We used age-standardized incidence rate (ASIR) and age-standardized mortality rate (ASMR) (per 105 population) estimated AAPC via joinpoint regression and applied auto-regressive integrated moving average (ARIMA) model to forecast rates. Results Higher incidence of lung cancer among men was observed in the south, north and north-east regions of India. Highest ASIR was in Srinagar (39.5) and highest ASMR in Aizawl (27.1). Among women, highest rates were observed in the north-east, particularly in Aizawl (ASIR:33.7, ASMR:23.2). Tobacco use among women remains low outside the north-east, correlating with the patterns of lung cancer. Mortality to incidence ratio was low (<30%) except in a few populations. An increasing-trend in incidence was noted, with the highest AAPC in Thiruvananthapuram (women:6.7) and Dindigul (men:4.3). Adenocarcinoma has emerged as the dominant subtype over 25 yr, with higher prevalence among women, especially in Bengaluru (56.0%). Large-cell carcinoma increased notably in Delhi. By 2030, ASIRs are projected to range from 1.8 (Barshi) to 33.1 (Kollam) in men, and 1.9 (Barshi) to 8.1 (Bengaluru) in women. Interpretation & conclusion The burden of lung cancer in India shows regional disparities, with more adenocarcinoma, especially among women. Incidence is projected to rise, while low mortality to incidence ratio suggests underreported mortality, underscoring the need for better death reporting. Region-specific research beyond tobacco use is essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.